Read Time:8 Second
Gilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection for HIV prevention was found 100% effective in a late-stage trial.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
